Korean Journal of Pharmacognosy (생약학회지)

The Korean Society of Pharmacognosy (한국생약학회)
권호 표지

Effects of Berberine on 6-hydroxydopamine-induced Parkinsonism in Rats

Berberine이 백서의 6-hydroxydopamine-유도 파킨슨병 모델에 미치는 영향

  • Published : 2009.12.31
Download PDF
⟨ Previous Next ⟩

Abstract

Many isoquinoline alkaloids including berberine lower dopamine content by reducing tyrosine hydroxylase (TH) activity and aggravate L-DOPA-induced cytotoxicity in PC12 cells. In this study, the effects of berberine on 6-hydroxydopamine (6-OHDA)-induced cytotoxicity in PC12 cells and on unilateral 6-OHDA-lesioned rat models were investigated. Berberine at 10-30 ${\mu}M$ did not affect cell viability in PC12 cells. However, berberine at concentrations higher than $50{\mu}M$ caused cytotoxicity at 24 h. Berberine (10-50 ${\mu}M$) also enhanced 6-OHDA (10-50 ${\mu}M$)-induced cytotoxicity at 24 h compared to 6-OHDA alone with an apoptotic process. In addition, treatment with berberine (5 and 30 mg/kg, i.p.) for three weeks showed a dopaminergic cell loss in substantia nigra of 6-OHDA-lesioned rats: 30 mg/kg berberine was more intensive cytotoxic. The levels of dopamine were also decreased by berberine (5 and 30 mg/kg) in the ipsilateral substantia nigra of 6-OHDA-lesioned rats. These results suggest that berberine aggravated 6-OHDA-induced cytotoxicity in PC12 cells and treatment with berberine (5 and 30 mg/kg) in 6-OHDA-lesioned rats also enhanced the degeneration of dopaminergic cell death and the decrease in dopamine levels in substantia nigra. Therefore, the long-term L-DOPA therapeutic patients with isoquinoline compounds including berberine may need to be checked for the adverse symptoms.

Keywords

References

  1. Fearnley, M. and Lees, A. J. (1991) Ageing and Parkinson's disease: substantia nigra regional selectivity. Brain. 114: 2283-2301 https://doi.org/10.1093/brain/114.5.2283
  2. McNaught, K. S., Carrupt, P. A., Altomare, C., Cellamare, S., Carotti, A., Testa, B., Jenner, P. and Marsden, C. D. (1998) Isoquinoline derivatives as endogenous neurotoxins in the aetiology of Parkinson's disease. Biochem. Pharmacol. 56: 921-933 https://doi.org/10.1016/S0006-2952(98)00142-7
  3. Jung, Y. J. and Surh, Y. J. (2001) Oxidative DNA damage and cytotoxicity induced by copper-stimulated redox cycling of salsolinol, a neurotoxic tetrahydroisoquinoline alkaloid. Free Rad. Biol. Med. 30: 1407-1417 https://doi.org/10.1016/S0891-5849(01)00548-2
  4. Shin, J. S., Kim, E. I., Kai, M. and Lee, M. K. (2000) Inhibition of dopamine biosynthesis by protoberberine alkaloids in PC12 cells. Neurochem. Res. 25: 363-368 https://doi.org/10.1023/A:1007541020736
  5. Shin, J. S., Kim, K. T. and Lee, M. K. (1998) Inhibitory effects of bulbocapnine on dopamine biosynthesis in PC12 cells. Neurosci. Lett. 244: 161-164 https://doi.org/10.1016/S0304-3940(98)00148-7
  6. Shin, J. S., Lee, J. J., Kim, Y., Lee, C. K., Yun, Y. P. and Lee, M. K. (2001) Inhibitory effects of ethaverine, a homologue of papaverine, on dopamine content in PC12 cells. Biol. Pharm. Bull. 24: 103-105 https://doi.org/10.1248/bpb.24.103
  7. Shin, J. S., Yun-Choi, H. S., Kim, E. I. and Lee, M. K. (1999) Inhibitory effects of higenamine on dopamine content in PC12 cells. Planta Med. 65: 452-455 https://doi.org/10.1055/s-2006-960810
  8. Yin, S. Y., Kim Y. M., Lee, J. J., Jin, C. M., Yang, Y. J., Ma, J. J., Kang, M. H., Kai, M. and Lee, M. K. (2004) Enantioselective inhibition of (1R,9S)- and (1S,9R)-$\beta$-hydrastines on dopamine biosynthesis in PC12 cells. Neuropharmacol. 47: 1045-1052 https://doi.org/10.1016/j.neuropharm.2004.07.033
  9. Kim, Y, M., Kim, M, N., Lee, J. J. and Lee, M. K. (2005) Inhibition of dopamine biosynthesis by tetrahydropapaveroline. Neurosci. Lett. 386: 1-4 https://doi.org/10.1016/j.neulet.2005.04.105
  10. Kim, S. H., Shin, J. S., Lee, J. J., Yin, S. Y., Kai, M. and Lee, M. K. (2001) Effects of hydrastine derivatives on dopamine biosynthesis in PC12 cells. Planta Med. 67: 609-613 https://doi.org/10.1055/s-2001-17356
  11. Zhang, Y. H., Shin, J. S., Lee, S. S., Kim, S. H. and Lee, M. K. (1997) Inhibition of tyrosine hydroxylase by bulbocapnine. Planta Med. 63: 362-363 https://doi.org/10.1055/s-2006-957702
  12. Jin, C. M., Lee, J. J., Yang, Y. J., Kim, Y. K., Ryu, S. Y. and Lee, M. K. (2007) Liriodenine inhibits dopamine biosynthesis and L-DOPA-induced dopamine content in PC12 cells. Arch. Pharm. Res. 30: 984-990 https://doi.org/10.1007/BF02993967
  13. Lee, M. K. and Zhang, Y. H. (1996) Inhibition of tyrosine hydroxylase by berberine. Med. Sci. Res. 24: 561-564
  14. Lee, S. S., Kai, M. and Lee, M. K. (1996) Effects of natural isoquinoline alkaloids on monoamine oxidase activity in mouse brain: Inhibition by berberine and palmatine. Med. Sci. Res. 27: 749-751
  15. Lee, S, S., Yun-Choi, H. S., Kim, E. I. and Lee, M. K. (1996) Inhibition of monoamine oxidase by higenamine. Med. Sci. Res. 26: 71-72
  16. Naoi, M., Matsuura, S., Parvez, H., Takahashi, T., Hirata, Y., Minami, M. and Nagatsu, T. (1989) Oxidation of N-methyl-1,2,3,4-tetrahydroisoquinoline into the N-methyl-isoquinolinium ion by monoamine oxidase. J. Neurochem. 52: 653-655 https://doi.org/10.1111/j.1471-4159.1989.tb09170.x
  17. Lee, J. J., Kim, Y. M., Yin, W. Y., Park, H. D., Kang, M. H., Hong, J. T. and Lee, M. K. (2003) Aggravation of L-DOPAinduced neurotoxicity by tetrahydropapaveroline in PC12 cells. Biochem. Pharmacol. 66: 1787-1795 https://doi.org/10.1016/S0006-2952(03)00421-0
  18. Maruyama, W., Nakahara, D., Ota, M., Takahashi, T., Takahashi, A., Nagatsu, T. and Naoi, M. (1992) N-Methylation of dopamine-derived 6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, (R)-salsolinol, in rat brains: In vivo microdialysis study. J Neurochem. 59: 395-400 https://doi.org/10.1111/j.1471-4159.1992.tb09384.x
  19. Naoi, M., Matsuura, S., Takahashi, T. and Nagatsu, T. (1989) A N-methyltransferase in human brain catalyses N-methylation of 1,2,3,4-tetrahydroisoquinoline into N-methyl-1,2,3,4-tetrahydroisoquinoline, a precursor of a dopaminergic neurotoxin, N-methylisoquinolinium ion. Biochem. Biophys. Res. Comm. 161: 1213-1219 https://doi.org/10.1016/0006-291X(89)91371-5
  20. Franzblau, S. G. and Cross, C. (1986) Comparative in vitro antimicrobial activity of chinese medicinal herbs. J. Ethnopharmacol. 15: 279-288 https://doi.org/10.1016/0378-8741(86)90166-2
  21. Yamahara, J. (1976) Behavioral pharmacology of berberinetype alkaloids (1), Central depressive action of Coptis Rhizoma and its constituents. Nippon Yakurigaku Zasshi. 72: 899-908 https://doi.org/10.1254/fpj.72.899
  22. Chen, H. C. and Hsieh, M. T. (1986) Two-year experience with 'San-Huang-Hsih-Tang; in essential hypertension. Am. J. Chin. Med. 14: 51-58 https://doi.org/10.1142/S0192415X86000090
  23. Takase, H., Imanishi, K., Miura, O. and Yumioka, E. (1989) A possible mechanism for the gastric mucosal protection by Oren-Gedoku-To (OGT), A traditional herbal medicine. Jpn. J. Pharmacol. 51: 17-23 https://doi.org/10.1254/jjp.51.17
  24. Bereese, G. and Traylor. T. (1970) Effect of 6-hydroxydopamine on brain norepinephrine and dopamine: evidence for selective degeneration of catecholamine neurons. J. Pharmacol. Exp. Ther. 175: 413-420
  25. Blum, D., Wu, Y., Nissou, M.-F., Arnaud, S., Benabid, A.-L. and Verna, J.-M. (1997) p53 and Bax activation in 6-hydroxydopamine-induced apoptosis in PC12 cell. Brain Res. 751: 139-142 https://doi.org/10.1016/S0006-8993(96)01358-3
  26. Greene, L.,A. and Tischler, A. S. (1976) Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. Proc. Natl. Acad. Sci. USA. 73: 2424-2428 https://doi.org/10.1073/pnas.73.7.2424
  27. Paxinos, G. and Watson, C. (1986) The rat brain in stereotaxic coordinates. Australia: Academic Press
  28. Mitsui, A., Nohta, H. and Ohkura, Y. (1985) High-performance liquid chromatography of plasma catecholamines using 1,2-diphenylethylenediamine as precolumn fluorescence derivatization reagent. J. Chromatogr. 344: 61-70 https://doi.org/10.1016/S0378-4347(00)82007-1
  29. Lowry, O. H., Rosenbrough, N. L., Farr, A. L. and Randall, R. L. (1951) Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193: 265-275
  30. 이재준, 김유미, 김춘매, 양유정, 강민희, 이명구. (2003) Protoberberine 알카로이드가 PC12 세포중의 L-DOPA 유도 세포독성 작용에 미치는 영향. 약학회지 47: 230-233
  31. Saito, Y., Nishio, K., Ogawa, Y., Kinumi, T., Yoshida, Y., Masuo, Y. and Niki, E. (2007) Molecular mechanisms of 6-hydroxydopamine-induced cytotoxicity in PC12 cells: Involvement of hydrogen peroxide-dependent and -independent action. Free Rad. Biol. Med. 42: 675-685 https://doi.org/10.1016/j.freeradbiomed.2006.12.004
  32. Perese, D, A., Ulman, J., Viola, J., Ewing, S. E. and Bankiewicz, K. S. (1989) A 6-hydroxydopamine-induced selective parkinsonian rat model. Brain Res. 494: 285-293 https://doi.org/10.1016/0006-8993(89)90597-0
  33. Jenner, P. and Olanow, C. W. (1996) Pathological evidence for oxidative stress in Parkinson's disease and related degenerative disorders. In: C.W. Olanow, P. Jenner and M. Youdim. (ed.) Neurodegeneration and Neuroprotection in Parkinson's Disease. 23-45, Academic Press, London
  34. Fahn, S. and Cohen, G. (1992) The oxidant stress hypothesis in Parkinson’s disease: Evidence supporting it. Ann. Neurol. 32: 804–812 https://doi.org/10.1002/ana.410320616
  35. Migheli, R., Godani, C., Sciola, L., Delogu, M. R., Serra, P. A., Zangani, D., De Natale, G., Miele, E. and Desole, M. S. (1999) Enhancing effect of manganese on L-DOPA-induced apoptosis in PC12 cells: Role of oxidative stress. J. Neurochem. 73: 1155-1163 https://doi.org/10.1046/j.1471-4159.1999.0731155.x